LHX2 haploinsufficiency causes a variable neurodevelopmental disorder

Genet Med. 2023 Jul;25(7):100839. doi: 10.1016/j.gim.2023.100839. Epub 2023 Apr 11.

Abstract

Purpose: LHX2 encodes the LIM homeobox 2 transcription factor (LHX2), which is highly expressed in brain and well conserved across species, but it has not been clearly linked to neurodevelopmental disorders (NDDs) to date.

Methods: Through international collaboration, we identified 19 individuals from 18 families with variable neurodevelopmental phenotypes, carrying a small chromosomal deletion, likely gene-disrupting or missense variants in LHX2. Functional consequences of missense variants were investigated in cellular systems.

Results: Affected individuals presented with developmental and/or behavioral abnormalities, autism spectrum disorder, variable intellectual disability, and microcephaly. We observed nucleolar accumulation for 2 missense variants located within the DNA-binding HOX domain, impaired interaction with co-factor LDB1 for another variant located in the protein-protein interaction-mediating LIM domain, and impaired transcriptional activation by luciferase assay for 4 missense variants.

Conclusion: We implicate LHX2 haploinsufficiency by deletion and likely gene-disrupting variants as causative for a variable NDD. Our findings suggest a loss-of-function mechanism also for likely pathogenic LHX2 missense variants. Together, our observations underscore the importance of LHX2 in the nervous system and for variable neurodevelopmental phenotypes.

Keywords: ASD; Intellectual disability; LHX2; Microcephaly; NDD; Neurodevelopmental disorder.

MeSH terms

  • Autism Spectrum Disorder* / genetics
  • Haploinsufficiency / genetics
  • Humans
  • Intellectual Disability* / complications
  • Intellectual Disability* / genetics
  • LIM-Homeodomain Proteins / genetics
  • Neurodevelopmental Disorders* / pathology
  • Transcription Factors / genetics

Substances

  • LIM-Homeodomain Proteins
  • Transcription Factors
  • LHX2 protein, human